Hongda Co., Ltd. announced on January 28 that the phosphate series production facilities at its Shifang Phosphochemical Branch have successfully completed the shutdown for maintenance and equipment upgrades, and have fully resumed production on January 28, 2026.

PriceSeek Analysis:
Monoammonium Phosphate (MAP) – Bull-Bear Score: -1
The resumption of production at Hongda Co., Ltd.’s phosphate facilities increases market supply, which may put downward pressure on spot prices. The rise in supply alleviates the previous shortage caused by maintenance, but the overall risk of oversupply intensifies, exerting a generally bearish impact on prices.

Phosphoric Acid – Bull-Bear Score: -1
The restart of production facilities boosts phosphoric acid supply, shifting the supply-demand balance in the spot market toward a looser state, potentially leading to downward price pressure. After production resumes, the release of enterprise capacity increases inventory, posing a generally bearish impact on spot prices.